Multi-Center Randomized Controlled Trial of Relay- NYC's Nonfatal Overdose Response Program
Sponsor: Centers for Disease Control and Prevention
Listed as NCT04317053, this NA trial focuses on Opioid Overdose and remains completed. Sponsored by Centers for Disease Control and Prevention, it has been updated 12 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Dec 2024 — Present [monthly]
Completed NA
Phase: PHASE3 → NA
-
Sep 2024 — Dec 2024 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Feb 2024 — Jul 2024 [monthly]
Completed PHASE3
-
Aug 2023 — Feb 2024 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
▶ Show 7 earlier versions
-
Jun 2023 — Aug 2023 [monthly]
Active Not Recruiting PHASE3
-
Sep 2022 — Jun 2023 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
May 2022 — Sep 2022 [monthly]
Recruiting PHASE3
-
Jun 2021 — May 2022 [monthly]
Recruiting PHASE3
-
Jan 2021 — Jun 2021 [monthly]
Recruiting PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Apr 2020 — Dec 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centers for Disease Control and Prevention
- NYU Langone Health
For direct contact, visit the study record on ClinicalTrials.gov .